BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 4, 2017
View Archived Issues
AbbVie studies SC-007 in advanced colorectal and gastric cancers
Read More
Gq protein inhibition induces bronchorelaxation in asthma models
Read More
Zhejiang Vimgreen Pharma identifies novel PI3Kdelta inhibitors
Read More
New PI3K inhibitors synthesized at Bayer
Read More
Celyad reports initial results from THINK trial
Read More
Janssen divulges novel protein arginine N-methyltransferase 5 inhibitors
Read More
Vical's VL-2297 possibly eligible for limited use indication approval in U.S.
Read More
Blade Therapeutics patents novel calpain inhibitors
Read More
Transgene and Randox to develop multifunctional oncolytic immunotherapies
Read More
Raze Therapeutics discovers novel 3-PGDH inhibitors
Read More
AbbVie's Humira given orphan drug status for hidradenitis suppurativa in Japan
Read More
Ritter Pharmaceuticals raises funds for phase III program for RP-G28
Read More
Trispecific antibodies show protection against SHIV in macaques
Read More
Pulmatrix's Pulmazole receives second QIDP designation
Read More
Gilead Sciences acquisition of Kite Pharma complete
Read More
Ultragenyx Pharmaceutical, Dimension Therapeutics enter definitive merger agreement
Read More
X-Chem and Bayer expand drug discovery collaboration
Read More
Spero Therapeutics' SPR-741 well-tolerated in phase I study
Read More
RedHill Biopharma announces topline results from phase II study of Bekinda in IBS-D
Read More
Emergent BioSolutions completes acquisition of raxibacumab from GSK
Read More
Nimbus Therapeutics and Celgene begin alliance to develop immunology drugs
Read More
Saniona reaches third milestone under Michael J. Fox Foundation grant
Read More
New MAPT gene mutations identified in families with tauopathies
Read More
Iclaprim meets primary endpoint in phase III REVIVE-2 study
Read More
DiscGenics cleared to begin clinical testing of IDCT in U.S.
Read More
ImmunoMet Therapeutics commences phase I study of OXPHOS inhibitor
Read More
Boehringer Ingelheim applies for approval of empagliflozin/linagliptin in Japan
Read More
Fibrinogen-like protein 1 linked to obesity
Read More
FDA lifts clinical hold on phase IIb study of ATL-1102 in MS
Read More